English JNJ-61393215 Cited by user Medgirl131 on 14 May 2022 JNJ-61393215 is an orexin antagonist medication which is under development for the treatment of depression and anxiety disorders.
English ACT-539313 Cited by user Medgirl131 on 11 May 2022 ACT-539313 is an orexin antagonist medication which is under development for the treatment of binge eating disorder and was previously under development for the…